Cellazon

About Cellazon

Cellazon is a TechBio therapeutics company pioneering new approach to precision and personalized medicine. Our proprietary platform, PathwayPersona™, maps how cells communicate within patient samples to reveal disease-specific and patient-specific drug targets. This unbiased approach helps uncover new biological insights directly from patient samples for development of more effective therapies. Unlike AI-first approaches that rely on pre-curated datasets, Cellazon integrates systems biology with advanced analytics to capture the true complexity of human biology directly from patient samples. This allows us to enhance biological understanding across all stages of drug development to make the discovery of new therapies faster, more efficient, and more precise. The company is developing a proprietary pipeline of drug targets while also enabling industry partners to benefit from its insights through collaborative access to the platform.